During the past decade, Uddevalla Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uddevalla Hospital" #1 sponsor was "Johnny Ludvigsson" with 2 trials, followed by "Vastra Gotaland Region" with 2 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored, "Biolight AB" with 1 trials sponsored and "Danderyd Hospital" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uddevalla Hospital" #1 collaborator was "Diamyd Medical AB" with 2 trials as a collaborator, "Swedish Child Diabetes Foundation" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Centrallasarettet Västerås" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Uddevalla Hospital" are "Diabetes Mellitus, Type 1" (4 trials), "Multiple Myeloma" (2 trials), "Avascular Necrosis" (1 trials), "Blood Glucose" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Uddevalla Hospital" in a lesser frequency.

Most popular intervention types in "Uddevalla Hospital" are "Drug" (6 trials), "Device" (4 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vitamin D" (2 trials), "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "Altemeier's operation" (1 trials), "Arcos Revision Stem System" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uddevalla Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Uddevalla Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Uddevalla Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uddevalla Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".